Latest news
Lilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo - ReutersReuters · Wed, 05 Aug 2026 17:51:09 GMTAdaptHealth Earnings Call: Growth Tempered by Cost Headwinds - TipRanksTipRanks · Wed, 05 Aug 2026 09:40:28 GMTPODD Q2 Deep Dive: Retention Challenges in Type 2 Diabetes Temper Growth Outlook - StockStoryStockStory · Wed, 05 Aug 2026 07:00:00 GMT